Navidea Biopharma (NAVB) Shares Tick Higher on Positive CHMP Opinion for Lymphoseek

September 16, 2016 8:20 AM EDT

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

Navidea Biopharma (NYSE: NAVB) shares are markedly higher amid a positive CHMP opinion on Lymphoseek issued this week. The stock is up nearly 9 percent in premarket trading.

For more color, click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Trader Talk

Add Your Comment